Literature DB >> 7342172

Rehydration in the treatment of severe hypercalcaemia.

D J Hosking, A Cowley, C A Bucknall.   

Abstract

Sixteen episodes of severe hypercalcaemia (more than 3.25 mmol/l) were treated by rehydration alone. Sodium repletion was invariably achieved within 48 hours (mean deficit 9.24 mmol/kg) although the fall in serum calcium was more protracted. A substantial fall in serum calcium (mean decrease 0.6 mmol/l) was achieved in thirteen patients; poor responses in three patients were associated with a rapidly increasing calcium load. Presentation of the data in terms of calcium excretion per unit of glomerular filtrate (CaE) and the setting of tubular reabsorption (TmCa/GFR) makes it possible to predict the likely effects of rehydration and patients with non-metastatic hypercalcaemia are easily identified. Rehydration is simple and often effective in the early management of this common metabolic problem but it is important that therapeutic goals are realistic and the intrinsic limitations of rehydration recognized. This depends upon a clear idea of the contribution that the kidney makes to the hypercalcaemia of malignant disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7342172

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  31 in total

1.  Severe hypocalcaemia after being given intravenous bisphosphonate.

Authors:  Rajesh Peter; Vinita Mishra; William D Fraser
Journal:  BMJ       Date:  2004-02-07

Review 2.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy.

Authors:  S Fatemi; F R Singer; R K Rude
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

Review 4.  [Metabolic disorders as paraneoplastic syndromes].

Authors:  S Krug; P Michl
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

Review 5.  Assessment of renal and skeletal components of hypercalcemia.

Authors:  D J Hosking
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

Review 6.  Symptom management in metastatic breast cancer.

Authors:  William Irvin; Hyman B Muss; Deborah K Mayer
Journal:  Oncologist       Date:  2011-08-31

7.  Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.

Authors:  S R Heller; D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

8.  Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.

Authors:  S H Ralston; I Fogelman; M D Gardiner; I T Boyle
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

Review 9.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

10.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.